Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

12 Health Care Stocks Moving In Tuesday's Pre-Market Session

Author: Benzinga Insights | August 23, 2022 08:31am

 

Gainers

  • Windtree Therapeutics (NASDAQ:WINT) shares increased by 67.4% to $0.77 during Tuesday's pre-market session. The market value of their outstanding shares is at $23.5 million.
  • Quotient (NASDAQ:QTNT) shares increased by 41.75% to $0.28. The market value of their outstanding shares is at $37.3 million.
  • Aerie Pharmaceuticals (NASDAQ:AERI) shares rose 35.69% to $15.13. The company's market cap stands at $746.8 million.
  • Acorda Therapeutics (NASDAQ:ACOR) stock moved upwards by 20.78% to $0.52. The market value of their outstanding shares is at $12.6 million.
  • Precigen (NASDAQ:PGEN) shares rose 17.56% to $2.41. The company's market cap stands at $501.6 million.
  • BIMI Intl Medical (NASDAQ:BIMI) stock moved upwards by 10.59% to $0.62. The market value of their outstanding shares is at $17.5 million. The company's, Q2 earnings came out yesterday.

Losers

  • Cellectar Biosciences (NASDAQ:CLRB) stock decreased by 36.4% to $3.5 during Tuesday's pre-market session. The company's market cap stands at $21.3 million.
  • Aspira Womens Health (NASDAQ:AWH) shares decreased by 27.28% to $0.64. The company's market cap stands at $71.8 million.
  • Assertio Holdings (NASDAQ:ASRT) stock decreased by 25.28% to $2.72. The company's market cap stands at $131.0 million.
  • Allarity Therapeutics (NASDAQ:ALLR) stock declined by 13.82% to $1.31. The market value of their outstanding shares is at $13.0 million.
  • AnPac Bio-Medical Science (NASDAQ:ANPC) stock fell 13.79% to $0.31. The market value of their outstanding shares is at $12.0 million.
  • Kiromic BioPharma (NASDAQ:KRBP) shares decreased by 11.2% to $0.37. The company's market cap stands at $5.9 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Posted In: ACOR AERI ALLR ANPC ASRT AWH BIMI CLRB KRBP PGEN QTNT WINT

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist